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Yersinia pestis, a Gram-negative bacterium and the etiologic agent of plague, has evolved
from Yersinia pseudotuberculosis, a cause of a mild enteric disease. However, the
molecular and biological mechanisms of how Y. pseudotuberculosis evolved to such
a remarkably virulent pathogen, Y. pestis, are not clear. The ability to initiate a rapid
bacterial dissemination is a characteristic hallmark of Y. pestis infection. A distinguishing
characteristic between the two Yersinia species is that Y. pseudotuberculosis strains
possess an O-antigen of lipopolysaccharide (LPS) while Y. pestis has lost the O-antigen
during evolution and therefore exposes its core LPS. In this study, we showed that Y.
pestis utilizes its core LPS to interact with SIGNR1 (CD209b), a C-type lectin receptor
on antigen presenting cells (APCs), leading to bacterial dissemination to lymph nodes,
spleen and liver, and the initiation of a systemic infection. We therefore propose that
the loss of O-antigen represents a critical step in the evolution of Y. pseudotuberculosis
into Y. pestis in terms of hijacking APCs, promoting bacterial dissemination and causing
the plague.
Keywords: Yersinia pestis, SIGNR1 (CD209b), macrophages, dendritic cells (DCs), antigen presenting cells
(APCs), core lipopolysaccharide/lipooligosaccharides (core LPS/LOS), bacterial dissemination, host-pathogen
interactions
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INTRODUCTION
Yersinia pestis is the bacterium that causes bubonic, septicemic,
and pneumonic forms of plague and that was the cause of
the Black Death in Europe during the middle ages. Recent
studies have proved that all three suspected plague pandemics
(the Justinian, the Black Death and the third pandemic) were
caused by this bacterium (1–6). Based on a study (7), the
New York Times on October 31, 2010 reported that the plague
pathogen responsible for all known plague pandemics in the
recorded history of human civilization might have originated
in China, but more likely from Eurasia (8, 9). Y. pestis
directly evolved from Y. pseudotuberculosis, the cause of a
self-limited mesenteric lymphadenitis, within the last 2,600 to
28,000 years (6, 7, 10–12). The apparent question is how did
Y. pseudotuberculosis evolve into such a virulent, dangerous and
remarkably different pathogen, Y. pestis? Could there still be an
ancestral Y. pseudotuberculosis circulating in China that might
hold clues to the evolution to Y. pestis?
A distinguishing difference between these pathogens
is that Y. pseudotuberculosis contains an O-antigen of
lipopolysaccharide (LPS), which was lost by Y. pestis during its
evolution (13–15) (Figure 1B). LPS plays a major role in the
pathogenicity of Gram-negative bacterial pathogens including
pathogenic species of the genera Escherichia, Shigella, Klebsiella,
Yersinia, and Salmonella. The presence of LPS promotes toxicity
as well as resistance to phagocytosis and serum-dependent
(complement-dependent) killing (16–21). LPS generally consists
of three structural regions: (i) the lipid A backbone, (ii) an
oligosaccharide core (core LPS), and (iii) the somatic O-
polysaccharide outer region (also called O-antigen, O-specific
antigen, or O-specific side chain) (Figure 1A). Gram-negative
bacteria are classified as smooth or rough based on the presence
or lack of the O-antigen (O-Ag), respectively. Y. pestis does not
contain an O-antigen (14, 15) and therefore the shortened LPS
is also referred to as lipooligosaccharide (LOS). Why would Y.
pseudotuberculosis sacrifice the production of O-Ag, one of its
key virulence factors, during the evolution to Y. pestis?
We have shown that human DC-specific intercellular
adhesion molecule-grabbing nonintegrin (hDC-SIGN, CD209a),
a C-type lectin receptor on antigen presenting cells (APCs) such
as macrophages and dendritic cells (DCs), is a receptor for
the core LPS of several Gram-negative bacteria, including E.
coli, Haemophilus ducreyi, Neisseria gonorrhoeae, Yersinia spp.,
and Salmonella typhimurium, promoting bacterial adherence
and phagocytosis (22–27). In addition, Y. pseudotuberculosis,
via its core LPS-CD209 interaction, may hijack APCs to be
disseminated to lymph nodes, spleen and liver (28).
Moreover, hDC-SIGN (CD209a) is a receptor for HIV gp120
that uses DC-SIGN to be captured and trafficked to target
cells such as CD4+ T cells (29–31). Mouse DC-SIGN-related
protein 1 (SIGNR1, CD209b), expressed on splenic marginal
zone, lymph nodes, and peritoneal macrophages, plays a role
in lymphocyte migration from the blood into tissues. Here, we
show that SIGNR1 is a cellular receptor for Y. pestis and that an
exposed core LPS is essential for the APCs/Y. pestis interaction,
host dissemination and infection. Therefore, it is possible that
the loss of expression of O-antigen during evolution from Y.
FIGURE 1 | Structures of O-antigen of Y. pseudotuberculosis and core LPS.
(A) Genes involved in the biosynthesis of O-antigen of Y. pseudotuberculosis.
*The genes were sequenced in this study. (B) Genes involved in the
biosynthesis of core LPS are shown at their approximate site of action (solid
line). The sites, which are variably substituted or still under investigation, are
indicated by dashed lines. Fuc, L-fucose; Gal, galactose; GalNAc,
N-Acetyl-galactosamine; Glc, glucose; GlcNAc, N-Acetylglucosamine; Hep,
heptose; KDO, 2-keto-3-deoxyoctonate; Man, mannose; P, phosphate; Par,
Paratose; PEA, phosphoethanolamine; PPEtn, phosphoethanolamine. It
should be noted that E. coli K12 and Y. pestis naturally do not possess
an O-antigen.
pseudotuberculosis might have endowed Y. pestis the ability to
hijack APCs in rodents in order to spread into lymph nodes and
initiate host infections (32, 33).
RESULTS
From the Perspective of O-Antigen
Synthesis Genes, Y. pestis Might Have
Evolved From One of Several Specific
Evolutionary Branches of
Y. pseudotuberculosis
Y. pseudotuberculosis strains possess an O-antigen, the
production of which was lost by Y. pestis during evolution. Based
on a recent study on the evolution of Y. pseudotuberculosis (12),
we sequenced six O-antigen synthesis genes (Figure 1A) just
outside ofwaaL (Figure 1B) of 39 strains of Y. pseudotuberculosis
and eight strains of Y. pestis to investigate the changes in these
genes during evolution (12). As shown in a summary (Figure 2),
unlike Y. pestis, the genes from the Y. pseudotuberculosis strains
showed extreme diversity, which echoes the conclusion of
the Cui’s study (12). However, there are several new findings;
(1) wbyL: Only one Y. pestis strain from the eight analyzed
showed a non-synonymous mutation in wbyL compared to Y.
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FIGURE 2 | Y. pseudotuberculosis rather than Y. pestis, isolated from China, show the multiple mutations of O-antigen synthesis genes. In the heatmap, rows
represent six O-antigen synthesis genes, and columns represent data from Y. pseudotuberculosis and Y. pestis strains. Red cell indicates the gene was detectable in
this strain while green cell indicates the gene was undetectable. In the phylogenetic tree, red branches are Y. pestis, and the rest are Y. pseudotuberculosis.
pseudotuberculosis. (2) wbyI: The wbyI genes from all eight Y.
pestis strains appeared to have lost their potential functions
due to the loss of a 62 base pair fragment presents in Y.
pseudotuberculosis. (3) gmd: The gmd gene in all eight Y. pestis
strains appeared to be non-functional due to an insertion. (4)
fcl: Only one strain of the eight Y. pestis strains (Orientalis, the
cause of third pandemic of plague) analyzed showed a deletion.
The other seven carried a fully functional gene. (5) wzy: Except
for one strain (Pestoides F), all the strains analyzed appeared to
have lost the function of this gene. (6) ddhB: Except for Pestoides
A (0.PE4c) and Microtus (0.PE4i), all lost function due to a
frame-shift mutation. It is reported that lack of O-antigen is
essential for plasminogen activation and invasiveness of Y. pestis
(34). Therefore, loss of genes involved in O-antigen synthesis in
Y. pestis affects its function.
In short, based on the detailed analysis of O-antigen synthesis
genes, we showed again that Y. pestis might evolve from one of
several specific evolutionary branches of Y. pseudotuberculosis.
The Core LPS of Y. pestis Is Involved in the
Invasion of Mouse Macrophages
Although the O-antigen synthesis genes in Y. pseudotuberculosis
are diverse, the core LPS appears to be identical to that of Y. pestis
(Figure 1B) (35, 36). Several Gram-negative bacterial strains
use their core LPS to interact with human DCs (22–24, 28).
Furthermore, another study showed that N-acetylglucosamine
(GlcNAc) within the core LPS (Figure 1B) may mediate the
interaction with DCs (24). To investigate the hypothesis that
Y. pestis might also use its core LPS to interact with mouse
macrophages, Y. pestis KIM10-1ail (a natural rough strain with
the core LPS exposed), and its two isogenic derivatives; KIM10-
1ail-O+ (a smooth strain in which the outer-core LPS is shielded
by O-antigen) and KIM10-1ail-Core− (with truncated LPS
outer-core, i.e., a deep rough strain) were examined for their
ability to invade mouse macrophages. Three corresponding E.
coli K-12 strains: CS180 (rough), CS1861 (CS180 expressing an
O-antigen, smooth), and CS2429 (deep rough) were used as
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FIGURE 3 | Interaction of Y. pestis with mouse peritoneal macrophages
involves its core LPS. (A) Gentamicin protection- and (B) flow cytometry-based
assays were used to determine the invasion rate of these sets of E. coli
K-12(CS180, CS1861, and CS2429) and Y. pestis KIM10 (1ail, 1ail-O+ and
1ail-Core−) into purified mouse peritoneal macrophages. (B) CFDA-SE
labeled and unlabelled bacteria are indicated by open and filled symbols,
respectively. Data are representative of three independent experiments.
controls. We have used this set of strains in previous studies that
demonstrate that the exposure of the core LPS by several Gram-
negative bacteria is essential to initiate contact with human DCs
(22–24). Figure 3A shows that Y. pestis KIM10-1ail (rough) and
E. coli K12 180 (rough) invade mouse macrophages. In contrast,
both deep rough and smooth strains resulted in a reduced level of
invasion of mouse macrophages in both assays (Figures 3A,B).
All strains used were cultured at 26◦C, at which Y. pestis does
not produce the F1 capsule that blocks interaction with host cells
(37, 38). This result indicates that phagocytosis of these bacteria
by mouse macrophages involves the core LPS ligand. The fact
that the O-antigen-expressing and the deep rough-Y. pestis still
interact with these host cells, although at a reduced level, suggests
that besides the core LPS, other components of Y. pestis also
mediate interactions with macrophages.
In addition, deep rough mutants of Gram-negative bacteria
in general are more sensitive to biological killing (39, 40). This
fact should be taken into consideration in interpreting the data
from the gentamicin survival assay of KIM10-1ail-Core− and
CS2429 (Figure 3A).
Murine SIGNR1 Is a Receptor for the Core
LPS of Y. pestis
Signr1 (CD209b), but Not the mDC-SIGN (CD209a) Is
a Receptor for the Core LPS of Y. pestis
To determine if the invasion of Y. pestis into mouse macrophages
was a result of the interaction between Y. pestis and murine DC-
SIGN (mDC-SIGN), five CHO transfectants stably expressing
the mouse C-type lectin receptors mDC-SIGN, SIGNR1,
SIGNR3, mDEC-205 (CD205), and mLangerin (CD207) (41,
42) (Figure 4A) were infected with Y. pestis KIM10-1ail and
CS180. Y. pseudotuberculosis (Y1) grown at 26◦C was used
as a positive control in this experiment because it invades
most epithelial cell lines, including CHO (43), via the invasin-
integrin interaction (44, 45). The expression of each C-type
lectin is shown in Figure 4B. CHO-SIGNR1, but not other C-
type lectin transfectants including CHO-mDC-SIGN, efficiently
phagocytized Y. pestisKIM10-1ail and CS180 (Figure 4A). Since
macrophages from the mouse peritoneal cavity express SIGNR1
(Figure 8B) (41, 42), it is anticipated that the phagocytosis
of Y. pestis by these macrophages involves the SIGNR1-core
LPS interaction.
GlcNAc Epitope Within the Core LPS of Y. pestis May
Play a Role in Interaction With SIGNR1
To confirm that a specific sugar epitope within the core LPS
is responsible for interacting with SIGNR1, another set of
core LPS mutants from Y. pestis strain D27 (46) was utilized
(Figure 1B and Table 1). Consistent with the results obtained for
E. coli (22), Salmonella (24), Neisseria gonorrhoeae (23), Neisseria
meningitidis (52), H. ducreyi (24), and Y. pseudotuberculosis
(28), the rough Y. pestis strain (wild-type) (25), rather than
the O-antigen expressing Y. pestis promoted a typical SIGNR1-
mediated adherence and phagocytosis (Figure 5). Furthermore,
the deletion of the GlcNAc epitope in the waaL mutant
(Figure 1B) reduced the ability of Y. pestis to interact with
CHO-SIGNR1, indicating again that the core LPS is the ligand.
Interestingly, phagocytosis of the Y. pestis mutants by CHO-
SIGNR1 was consistent with the idea that the lengthier the core
LPS is, the greater the ability to promote phagocytosis, as shown
with Salmonella (24).
The results from Figures 3–5 lead to three conclusions.
First, SIGNR1 is a receptor for Y. pestis. Second, the core LPS
of Y. pestis as a ligand is involved in this interaction. Third,
GlcNAc is important for the SIGNR1 interaction (24). In fact,
the data published 2015 in Immunology and Cell Biology (27),
regarding the interaction of human CD207, awarded an editorial
comments, entitled “A new cellular target forYersinia pestis” (53).
Y. pestis Invades Mouse Macrophage Cell
Lines That Express Limited SIGNR1
Y. pestis invades certain macrophage cell lines, such as the
J774A.1 (54, 55). In order to determine if the same ligands
are involved in this interaction as was found with primary
macrophages (Figure 3A) and CHO-SIGNR1 (Figures 4, 5),
the KIM10-1ail and KIM10-1ail-O+ were examined for their
ability to invade two macrophage cell lines, J774A.1, and CRL-
2455 (Figure 6A). The expression level of SIGNR1 on J774A.1
is shown in Figure 6B, but the expression of this receptor on
CRL-2455 cell line was undetectable (Figure 6B).
The interaction of the KIM10-1ail and KIM10-1ail-O+
with J774A.1 resembled the results obtained using primary
macrophages. KIM10-1ail invades host cells better than KIM10-
1ail-O+, and CS180 is also able to invade J774A.1 cells. However,
the CRL-2455 cell line, which does not express SIGNR1, is still
able to phagocytose low levels of both KIM10-1ail and KIM10-
1ail-O+, but not CS180, indicating that the core LPS does not
interact with the CRL-2455 cell line.
In short, these results indicated that other components or
mechanisms can also lead to internalization of Y. pestis by
macrophages, besides the core LPS-SIGNR1 interaction. Because
CS180 invades SIGNR1-expressing macrophage cell line, but not
the CRL-2455, it also confirms the core LPS-SIGNR1 interaction
with macrophages.
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FIGURE 4 | Y. pestis invades CHO-SIGNR1, but not other CHO transfectants. (A) The invasion of three bacteria; E. coli K-12 CS180, Y. pseudotuberculosis (Y1) and
Y. pestis KIM10-1ail into several CHO transfectants with the expression of mouse C-type lectins; CHO-mDC-SIGN, CHO-SIGNR1, CHO-SIGNR3, CHO-mDEC-205
(CD205), and CHO-mLangerin (CD207). CHO transfectants were incubated with the bacterial strains for 2.5 h and the extracellular bacteria were killed by 100µg/ml
of gentamicin. The number of intracellular bacteria was determined by counting the recovered CFUs. (B) The expression of level of each transfectant and CHO-Neo
was shown in open and filled curve, respectively. Data are representative of three independent experiments.
FIGURE 5 | A specific sugar epitope within core LPS may be responsible for
interacting with SIGNR1. Y. pestis 1418 (D27, wild type) and its mutants
(1418-O+, 5147 D27-1-waaQ, 5149 D27-1-waaE, 5150 D27-1-waaL, 5151
D27-1-wabD, and 5188 D27-1-waaA) that possess specific sugar epitope
within core LPS were used to determine the invasion rate. Y.
pseudotuberculosis (Y1) were used as control strains. Data are representative
of three independent experiments.
The Inhibition of SIGNR1-Mediated
Phagocytosis of Y. pestis by Anti-SIGNR1
Antibody, Mannan, Peptides, and
Oligosaccharides
To verify the specificity of the interaction of Y. pestis with
SIGNR1, we examined whether the core LPS-SIGNR1 interaction
could be inhibited by SIGNR1 antibody, mannan, His-Mermaid
and CD66 antibody. Mannan is a well-documented reagent for
its ability to block the DC-SIGN-mediated interactions with
HIV. His-Mermaid is the recombinant form of Mermaid,
a newly identified DC-SIGN-like protein (56) that has
previously been shown to inhibit the core-LPS-hDC-SIGN
interaction (24). Anti-CD66 antibody was employed as a control
antibody. E. coli K12 CS180 and Y. pseudotuberculosis serotype
O:1b, mediating a SIGNR1-dependent and -independent
interaction, respectively, were again utilized as control
strains. Figure 7A shows that the anti-SIGNR1 and mannan
inhibit the interaction between Y. pestis or CS180 and CHO-
SIGNR1, indicating a specific interaction between SIGNR1-
Y. pestis, which promotes the invasion of this bacteria into
mouse APCs.
Mermaid possesses the ability to inhibit hDC-
SIGN-mediated interaction with several Gram-negative
bacteria (24), but the inhibition of the Y. pestis-SIGNR1
interaction by Mermaid is limited (Figure 7A), suggesting
that hDC-SIGN and SIGNR1 have distinguishing
features employed during interactions with core LPS of
Y. pestis (41, 42).
Certain oligosaccharides inhibit CS180-HeLa-hDC-SIGN-
promoted interaction (24). Figures 7B,C show that although
these reagents have very limited abilities to inhibit the
SIGNR1-mediated interaction, but the β-D-Gal-(1→3)-D-
GalNAc (A0167), β-D-Gal-(1→6)-D-GlcNAc (A7916) and
α-NeuNAc-(2→3)-β-D-Gal-(1→4)(α-L-Fuc-)-D-GlcNAc
(S1782) oligosaccharides inhibit the core-LPS-hDC-SIGN
interaction of Y. pestis KIM10-1ail very well (25). The recovery
rates of Y1 and KIM10-1ail bacteria in both cell lines are
dramatically reduced in the presence of lactoferrin, indicating
that these bacteria are killed by this peptide, which is well-known
for its ability to kill bacteria (57).
In short, the results also indicated that hDC-SIGN (hCD209a)
and SIGNR1 (CD209b) are different in terms of their interactions
with Y. pestis.
In vivo Phagocytosis of Y. pestis by Mouse
Macrophages Involves the Core LPS
Yesinia pestis can invade macrophages as well as other APCs
during infection in mice (32, 58, 59). To test whether the
core LPS-mediated interaction also occurs in vivo, we injected
bacterial suspensions directly into the mouse peritoneal cavity.
This approach is analogous to our previous study showing
that the interaction of mouse CD205 (DEC-205) receptor on
alveolar macrophages with the Y. pestis plasminogen activator
(Pla) occurs in vivo (26).
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TABLE 1 | Bacterial strains, cell lines used in this study.
Strains Genotypes (phenotypes) References
Yersinia pestis
KIM6 Lcr–, Pgm+, Pst+, wild type (rough) (47)
KIM10-1ail Derivative of KIM5 in which the ail gene has been deleted and both plasmid pCD1 and pPCP1 have been cured (48)
KIM10-1ail-O+ KIM10-1ail expessing O-antigen This work
KIM10-1ail-Core- Deep rough mutant derivative of KIM10-1ail, Truncated LPS outer-core This work
Y. pestis 1418 KIM D27 (Lcr+, Pgm−, Pst+) transformed with pBR322 plasmid This work
Y. pestis 1418-O+ Y. pestis 1418 transformed with pAY100.1 plasmid expressing an O-antigen from Y. enterocolitica serotype O:3 This work
Y. pestis 5150 KIM D27-1waaL (46)
Y. pestis 5151 KIM D27-1wabD (46)
Y. pestis 5147 KIM D27-1waaQ (46)
Y. pestis 5149 KIM D27-1waaE (46)
Y. pestis 5188 KIM D27-1waaA (46)
Y. pestis 91001 A fully virulent to mice (49)
Y. pseudotuberculosis
Y1 Serotype O:1a, wild-type expressing invasin, but with pYV plasmid naturally cured (smooth) (43)
E. coli K-12
CS180 Contains core LPS but lacks O-antigen (rough) (50, 51)
CS1861 CS180 expressing O-antigen (smooth) (50, 51)
CS2429 Lacking both O-antigen and most of core (waaC) (50, 51)
Cell lines Characteristics
HeLa-NEO cells Control cell line, which expresses the neomycin resistance gene only
HeLa-hDC-SIGN Generated by transfecting HeLa cells with human DC-SIGN cDNA for stable surface expression
CHO-NEO cells Control cell line, which expresses the neomycin resistance gene only
CHO-SIGNR1 cells Generated by transfecting CHO cells with mouse SIGNR1 cDNA for stable surface expression
CHO-mDC-SIGN cells Generated by transfecting CHO cells with mouse DC-SIGN cDNA for stable surface expression
CHO-SIGNR3 cells Generated by transfecting CHO cells with mouse SIGN-R3 cDNA for stable surface expression
CHO-CD205 cells Generated by transfecting CHO cells with mouse CD205 cDNA for stable surface expression
CHO-CD207 cells Generated by transfecting CHO cells with mouse CD207 cDNA for stable surface expression
Primary macrophage Primary macrophages from mouse peritoneal cavity
CRL-2455 Alveolar macrophage cell line
J774A.1 Macrophage cell line expressing SIGNR1
After 1.5 h of infection, the intraperitoneal fluids or exudates
were collected and placed in gentamicin media to kill the
extracellular bacteria. Figure 8A shows that a higher percentage
of viable Y. pestis was recovered compared to the O-antigen
expressing-Y. pestis, KIM10-1ail-O+. This increased recovery
rate of KIM10-1ail is not due to the ability of the O-antigen
to protect against complement-mediated killing (16–21), as in
the serum killing assay KIM10-1ail-O+ was more resistant
than KIM10-1ail (Figure 8C). In short, because KIM10-1ail-
O+ was more resistant than KIM10-1ail, the increased recovery
of KIM10-1ail suggests that core LPS-mediated phagocytosis of
Y. pestis occurs in vivo.
O-Antigen Expressing Y. pestis Have a
Reduced Ability to Be Disseminated to
Lymph Nodes
Our recently published data showed that Y. pseudotuberculosis
uses its core LPS to interact with hDC-SIGN and SIGNR1
receptors, leading to its dissemination (28). We therefore
hypothesized that the dissemination of Y. pestis to the lymph
node (LN), spleen and liver would also be facilitated by this host-
pathogen interaction. Subsequently, if the exposed core LPS of Y.
pestis could be shielded that should reduce dissemination.
Higher Numbers of Rough Rather Than Smooth
Y. pestis Bacteria Were Disseminated to LN, Spleen,
and Liver
To achieve a Y. pestis strain producing smooth LPS in vivo, we
introduced plasmid pAY100.1 into strain Y. pestis 1418. Plasmid
pAY100.1 carries the O-Ag gene cluster of Y. enterocolitica
serotype O:3 and produces the O-Ag (25, 27, 60, 61). Y. pestis
1418 (KIMD27) is a conditionally virulent strain, which is able to
cause typical plague in mice depending on the route of infection
and dose (Figure 9A) (46). As a control, the plasmid vector
pBR322 was transformed to Y. pestis 1418, which was described
in the previous publications (25–27). Mice were infected via
injection into hind paws and sacrificed after 72 h. LN, spleen
and liver were then homogenized. The dissemination rates of
the bacteria into the different organs were calculated by plating
and counting CFUs and fluorescent intensity. Figures 9A,C show
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FIGURE 6 | SIGNR1-mediated phagocytosis depends in part on core LPS. (A) The two sets of bacteria; E. coli K-12 strain (CS180 and CS1861) and Y. pestis
KIM10-1ail (1ail and 1ail-O+) were tested for whether the SIGNR1-mediated interaction is depended on this core LPS with CHO transfectants and macrophage cell
lines J774A.1 and CRL-2455. (B) The expression of SIGNR1 of these macrophage cell lines and control CHO-SIGNR1. Data are representative of three independent
experiments. ***P < 0.001.
that higher numbers of 1418 than 1418-O+ bacteria were isolated
from LN, spleen, and liver. It should be recognized that both
strains exhibited no differences in growth and adhered to both
HeLa and CHO cells (data not shown).
Higher Quantity of Bacterial DNA Was Detected in
MLNs, Livers and Spleens of Mice Infected With
Rough Than Smooth Y. pestis
The mice were challenged as described above, but the mice were
sacrificed after 8 h infection. The ail gene DNA of Y. pestis in LN,
spleen and liver was quantitated by real time PCR. The bacterial
load was higher in mice infected with Y. pestis 1418 than in Y.
pestis 1418-O+ (Figure 9B), which was consistent with the data
of bacterial recovery assay described above.
Evaluation of Dissemination With Bioluminescence
Imaging
C57BL/6J mice were subcutaneously inoculated in hind paws
with Y. pestis 1418 or 1418-O+ transformed with the pXEN-
luxCDABE (pXEN-18) plasmid, and bioluminescent signals
were monitored at 0, 48, and 72 h post inoculation (hpi). The
bioluminescent scale ranges from most intense (red) to least
intensity (violet) (Figure 9C). All images are standardized to
the same radiance scale. Bioluminescence was detected in the
abdomen and thoracic region of the mice at 48 hpi (data not
shown), but the highest level of signal was observed in the region
corresponding to liver and spleen at 72 hpi. Signals from the
mice infected with Y. pestis 1418-O+ were significantly increased
in intensity than those in Y. pestis1418 group, suggesting
the dissemination ability of O-antigen expressing Y. pestis
was reduced.
The Phagocytosis of Y. pestis by Macrophages and
Host Dissemination in SIGNR1 Knock-Out Mice Were
Reduced
To demonstrate the involvement of SIGNR1 in the interaction
of Y. pestis and macrophages in vivo, we evaluated the
phagocytic and intracellular killing capacity of peritoneal
macrophages derived from SIGNR1 knock-out (SIGNR1) mice.
The phagocytosis of Y. pestis by peritoneal macrophages
(Figure 9D) and host dissemination (Figure 9E) in by SIGNR1
KO mice were significantly reduced, indicating the direct
involvement of SIGNR1. However, the SIGNR1 KO mice were
shownmore susceptible to infection of Y. pestis 1418 (Figure 9F),
which is addressed in Discussion.
In summary, the results suggest that Y. pestis could utilize its
core LPS to interact with SIGNR1 to enhance the dissemination
in host tissues.
The Expression of O-Antigen Reduces the
Infectivity of Y. pestis
To examine whether the reduced dissemination, when the
interaction of core LPS-SIGNR1 interaction was blocked by
expression of O-antigen, leads to reduction of infection,
C57BL/6J mice were challenged with two sets of Y. pestis 1418
and 91001. Survival analyses following subcutaneous injection,
the route bubonic plague, revealed that the mice infected with
Y. pestis 1418 suffered from a significant survival disadvantage
compared to those infected with Y. pestis 1418-O+ (Figure 10A).
However, there is no difference with the intravenous inoculation
which mimic the septicemic plague (Figure 10B). Y. pestis
91001, a fully virulent strain isolated from China (62), was
used to challenge each mouse with 30 CFU via subcutaneous
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FIGURE 7 | The inhibition of SIGNR1-mediated phagocytosis of Y. pestis by
anti-SIGNR1 antibody, mannan, peptides, and oligosaccharides. (A) Y. pestis
(Continued)
FIGURE 7 | KIM10-1ail were incubated with CHO-SIGNR1 in the presence or
absence of anti-CD66, anti-SIGNR1, mannan and DC-SIGN-like protein
(His-Mermaid). The phagocytosis rate of Y. pestis was evaluated by the
recovery of bacteria from gentamicin protection. E. coli K12 180 and Y.
pseudotuberculosis serotype O:1b were used as control strains to show core
LPS-dependent or independent interaction with CHO-SIGNR1. (B,C) Various
oligosaccharides and lactoferrin were also tested for their ability to inhibit the
interaction of CHO-SIGNR1 and HeLa-hDC-SIGN with Y. pestis KIM10-1ail
and Y. pseudotuberculosis sero-type O:1b (Y. pstb). Data are representative of
three independent experiments.
inoculation. When cover the core LPS of Y. pestis 91001 with
the expression of O-antigen, the mice infected with Y. pestis
91001-O+ displayed significant survival advantage relative to Y.
pestis 91001 (Figure 10C). The results shown above demonstrate
that the exposure of core LPS is important for Y. pestis in host
dissemination and bacterial infection.
DISCUSSION
Y. pestis, the cause of plagues, has directly evolved from Y.
pseudotuberculosis within the last 2,600 to 28,000 years (7, 10,
11). It is well-documented that a distinguishing characteristic
between these two Yersinia species is that Y. pseudotuberculosis
strains possess an O-antigen (intact LPS expression), which
was lost by Y. pestis during evolution. As a result, after
entering the skin by an infected flea, Y. pestis, with its core
LPS, can directly interact with APCs, leading to phagocytosis
of the pathogen (25). The infected APCs consequently serve
as a Trojan Horse to deliver the Y. pestis to lymph nodes
(33) and initiate the plagues. In this study, we demonstrated
that it is the murine SIGNR1 that serves as a receptor for
the core LPS of Y. pestis to promote bacterial dissemination
and infection.
The current model for the initial stages in the pathogenic
process mediated by Y. pestis is reminiscent of how HIV-
1 infects hosts. It is well-established that HIV-1 pirates DC-
SIGN (CD209), a C-type lectin receptor expressed by APCs,
to be captured and transmitted to target cells such as CD4+
lymphocytes (29–31).
The connection between Y. pestis and HIV extends to another
receptor, CCR5, which is a co-receptor for HIV. There is evidence
that a certain subpopulation of Caucasians is resistant to HIV
infection because of their natural deletion of this receptor. It
has been suggested that human populations have also been
selected by Y. pestis, based on its sensitivity to human CCR5 (63).
Therefore, CCR5 knock-out mice were challenged with Y. pestis,
but no protection was observed (64, 65).
Besides showing that Y. pestis uses its core LPS to interact
with SIGNR1 in vitro, we designed and performed an in vivo
interaction assay to determine whether the core LPS-SIGNR1
interaction occurs in vivo between Y. pestis and macrophages.
Even so, the fundamental question remains as to whether core
LPS-SIGNR1 interaction plays a role in in vivo infections.
The straightforward approach is to test if SIGNR1 knock-
out mice would be resistant to plague, as KO mice have
Frontiers in Immunology | www.frontiersin.org 8 March 2019 | Volume 10 | Article 96
Yang et al. Y. pestis Hijacks CD209b for Dissemination
FIGURE 8 | Core LPS-SIGNR1 interaction with macrophages occurs in vivo. Y. pestis (KIM10-1ail and KIM10-1ail-O+) were tested for their ability to invade
macrophages in vivo. (A) Bacterial suspensions were inoculated into the mouse peritoneal cavity. After incubation for 1.5 h, macrophages were examined for the rate
of internalized bacteria. (B) The SIGNR1 expression of the mouse peritoneal macrophages. (C) KIM10-1ail-O+ was more resistant than KIM10-1ail in serum resistant
assay. *P < 0.05, ***P < 0.001. Data are representative of three independent experiments.
been used successfully to identify viral receptors. For example,
the CEACAM1 (CD66a) receptor KO mice have an increased
resistance to mouse hepatitis viral infection (66), because mouse
CEACAM1 is a receptor for mouse hepatitis virus (67). However,
there are potential limitations of this approach to study bacterial-
host cell interactions. Strangely, there are no credible receptor
knock-out models that are more resistant to bacterial infection.
The reason might be simple; viral infection is less complicated
than bacterial infections. One receptor might not be enough
to determine the fate of a bacterial infection, which might
contribute to the failure of CCR5-knock-out mice to resist Y.
pestis infection (64, 65), even if CCR5 were a receptor for Y.
pestis. In addition, SIGNR1 knock-out mice are more susceptible
to bacterial infection (68), probably because of the role of this
receptor in the complement pathway (69). In short, this strategy
could only work if SIGNR1 is the only, or a very prominent,
receptor for Y. pestis. Unfortunately, many pathogens do not
depend on only one receptor in their interactions with host cells.
The oligosaccharides and small peptide were chosen to analyse
their ability to inhibit Y. pestis-C-type lectin interactions for
the four following rationales: (1) Oligosaccharides that interfere
with the interaction between host cells and Y. pestis have been
examined for their therapeutic potential (70, 71). (2) Several
Gram-negative bacteria might use their core LPS, consisting of
oligosaccharides, to interact with hDC-SIGN, which could be
inhibited by oligosaccharides (24). (3) SIGNR1 binds to the
capsular polysaccharide of Streptococcus pneumoniae (68, 69, 72).
(4) HIV uses gp 120-DC-SIGN interaction to be captured by DCs
and transmitted to CD4+ cells (29–31). Therefore, blockage of
DC-SIGN-mediated transmission of HIV has been undertaken
by many investigators in order to find therapeutic strategies for
HIV infection. For example, lactoferrin, a small peptide from
milk, and Lewis X components (oligosaccharides) have been
shown to prevent DC-mediated HIV-1 transmission by blocking
the DC-SIGN-gp120 interaction (73, 74). Interestingly, our data
show that some oligosaccharides indeed inhibit the interaction
between Y. pestis and hDC-SIGN.
Taken together, this study has demonstrated that SIGNR1
is a cellular receptor for Y. pestis and possibly plays a role in
host dissemination and bacterial infection. Since hDC-SIGN and
SIGNR1 share a similar ability to interact with core LPS, we
speculate that Y. pestis may hijack APCs, through the core LPS-
SIGNR1 interaction, to reach the lymph nodes, utilizing a similar
mechanism as demonstrated in the HIV-hDC-SIGN interaction.
The knowledge acquired from this study may allow us to develop
novel strategies to combat this bacterial pathogen by blocking the
interaction between Y. pestis and host receptors.
MATERIALS AND METHODS
Ethics Statement
All animal procedures were carried out in strict accordance
with the guidelines of Institutional Animal Care and Use
Committees (IACUCs) and Institutional Review Board (IRB)
of Tongji Hospital, HUST. The handling of the mice and all
experimental procedures were specifically approved for this study
by the Medical Ethics Committee of Tongji Hospital and were
conducted in accordance with the institutional guidelines (IRB
ID: TJ-A20141220).
Bacterial Strains (Table 1)
E. coli K12 strain CS180 contains core LPS but lacks O-antigen
(75). CS1861 is the strain of CS180 harboring pSS37, a plasmid
containing all the genes necessary for the expression of the
Shigella dysenteriae 1 O-antigen (50, 51, 75). A deep rough
isogenic mutant CS2429 (waaC), lacking both O-antigen and
most of core (50, 51, 75), was used to assess the role of LPS in
bacterial-macrophage interactions. E. coli strains were cultured
on Luria-Bertani medium (LB) supplemented with 1.5% agar at
37◦C overnight.
Yersinia pseudotuberculosis (Y1) is a serotype O:1a strain,
lacking the virulence plasmid (pYV) and expression of Ail
protein. The strain was obtained from the CDC and used
as a control strain for invasion (43), since this bacterium
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FIGURE 9 | O-antigen expressing Y. pestis have a reduced ability to be disseminated to lymph nodes. (A) Y. pestis 1418 and 1418-O+ were examined for their ability
to be disseminated to lymph node, spleen and liver. (B) Bacterial load determined by real time PCR. (C) Dissemination of Y. pestis 1418 and 1418-O+ with pXEN-18
were monitored by the bioluminescence at 72 h post bacterial inoculation into hind paws of mice. (D) Reduction the phagocytosis of Y. pestis 1418 by peritoneal
macrophages of SIGNR1 KO mice. (E) Reduction in Y. pestis 1418 dissemination to lymph node in Y. pestis infected SIGNR1 KO mice at 5 hpi as compared to
infected WT mice. (F) Survival rates of WT mice and SIGNR1 KO mice after the infection of Y. pestis 1418. For each group, 10 mice were infected with 108 CFU Y.
pestis 1418 and observed until 15 days post infection. Log-rank test was performed. The data shown are obtained from the three independent experiments. *P <
0.05, **P < 0.01, ***P < 0.001.
invades almost all epithelial cell lines via an invasin-integrin
interaction (76).
The Y. pestis strain 1418 used in this study is originated from
KIM5 (KIM-D27), whose pgm (pigmentation) 104 kb locus has
been deleted (47, 48), and it is therefore classified as an avirulent
and non-selected strain. KIM10-1ail is a derivative of KIM5, in
which the ail gene has been deleted and its pPCP1 plasmid was
also cured (48). The KIM10-1ail used in this study is derivative
of KIM5 and was also pYV plasmid-cured strain, selected using
a combination of magnesium oxalate and Congo red selection
methods (77). KIM10-1ail-O+ that expresses an O-antigen from
Y. enterocolitica serotype O:3 (61) is an isogenic derivative of
KIM10-1ail. KIM10-1ail-Core− is also an isogenic derivative
of KIM10-1ail, in which the outer core LPS has been deleted
as described in the construction procedures shown below. Y.
pestis core LPS mutants 5147, 5149, 5150, 5151, and 5188 were
generously provided by Dr. Skurnik (46). Strains were cultured
on GC based-plates (Difco, Sparks, MD) supplemented with 1%
hemoglobin (USB Co., Cleveland, OH).
Construction of gmhA-Deletion Mutant by
Allelic Exchange
For construction of gmhA-deletion KIM10-1ail, we followed the
procedures described by Dr. Darby (78). The inner core structure
contains KDO linked to lipid A followed by heptoses to which the
outer core hexoses attach (Figure 1). Phosphoheptose isomerase,
encoded by gmhA, catalyzes the first step in the GDP-heptose
biosynthesis pathway (78). Y. pestis KIM6 gmhA mutants are
deep rough mutants as they do not make GDP-heptose that
results in truncation of the outer core of LPS (78). To construct
a deep rough mutant derivative of KIM10-1ail, the gmhA
allelic exchange plasmid pCBD41 was mobilized from E. coli
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FIGURE 10 | The expression of O-antigen reduces death rates by infection.
(A,B) Mice were subcutaneously and intravenously inoculated with Y. pestis
1418/1418-O+. (C) Mice were subcutaneously inoculated with Y. pestis
91001. The rates of mortality were recorded every 12 hpi. *P < 0.05.
SM10λpir/pCBD41 into KIM10-1ail. pCBD41 (a kind gift of Dr.
Greg Darby) contains two gmhA-flanking 900 bp PCR-amplified
fragments cloned into suicide vector pCVD442 (78). KIM10-1ail
transconjugants were selected on Yersinia selective agar (Difco)
containing chloramphenicol and ampicillin. As the suicide vector
replication requires the pir gene, which does not present in
Yersinia spp., the recovered KIM10-1ail transconjugants should
contain the plasmid cointegrated at the gmhA chromosomal
locus. The deletion of gmhA was confirmed by PCR assays using
the primers; GMHF 5′-GCTTGGATCCCATAATGAAGCTCC
TGAGATGTAG and GMHR 5′-AGTGGGTCGACACAGAAG
ATTGAGGTGATCAAC.
Construction of Y. pestis That Expresses
O-Antigen
The expression of O-antigen byY. pestiswas lost during evolution
from the ancestor, Y. pseudotuberculosis. To express the O-
antigen, Y. pestis strain 1418 was transformed with plasmid
pAY100.1 that carries all the necessary genes for the expression of
the O-ag of Y. enterocolitica serotype O:3 (60, 61). The expression
of O-antigen, coded by pAY100.1 plasmid, is not influenced by
growth temperature (25–27).
Cell Lines (Table 1)
Two mouse macrophage cell lines were purchased from ATCC.
The CRL-2455 is an alveolar macrophage cell line. J774A.1 was
selected, since this cell line shows its ability to phagocytose Y.
pestis when grown at 26◦C (54, 55).
Mouse C-type lectin tranfectants, CHO-mDC-SIGN, CHO-
SIGNR1, CHO-SIGNR3, CHO-mDEC-205 (CD205), and CHO-
mLangerin (CD207) were generated by transfecting CHO cells
(purchased from purchased from the Type Culture Collection of
the Chinese Academy of Sciences, Shanghai, China) with mouse
corresponding C-type lectin cDNA followed by selection for
stable surface expression as originally described (41). CHO-Neo
is the control cell line, which expresses the neomycin resistance
gene only.
HeLa-DC-SIGN cells were generated by transfecting HeLa
cells (purchased fromATCC, USA) with humanDC-SIGN cDNA
followed by selection for stable surface DC-SIGN expression as
originally described (79, 80). The cell lines were recently used for
identification of core LPS from several Gram-negative bacteria as
ligand for DC-SIGN receptor (22–24).
Mice
C57BL/6J and BALB/cJ were purchased from Wuhan University
Animal Center. SIGNR1 KO mice were kindly provided by
The Consortium for Functional Glycomics (CFG, http://www.
functionalglycomics.org) and bred in the animal facility of Tongji
Hospital. Mice were housed in direct accordance with guidelines
drafted by the Animal Care Committees of Tongji Hospital.
Biology Reagents
Anti-mouse SIGNR1 antibody was purchased from Pharmingen
(San Diego, CA). YTH71.3, a rat antibody which recognizes
CEACAM1 (CD66a), CEACAM6 (CD66c), and CEACAM3
(CD66d), was purchased from Roche (Indianapolis, IN).
Oligosaccharides: β-D-Gal-(1→6)-D-GlcNAc {2-Acetamido-
2-deoxy-6-O-(β-D-galactopyranosyl)-D-glucopyranose, A7916},
β-D-Gal-(1→4)-D-GlcNAc {N-Acetyl-D-lactosamine A7791},
β-D-Gal-(1→3)-D-GalNAc {Galacto-N-biose, A0167},
β-D-GlcNAc-(1→3)-β-D-Gal-1→OMe {(Methyl 3-O-(N-
acetyl-β-D-glucosaminyl)-β-D-galactopyranoside, M0775},
α-NeuNAc-(2→3)-β-D-Gal-(1→4)(α-L-Fuc-)-D-GlcNAc
{3’-Sialyl-Lewis-X tetrasaccharide, S1782} and β-D-GlcNAc-
(1→6)-β-D-Gal-(1→4)-D-Glc {β 6’-GlcNAc-lactose, A8297)},
mannan and lactoferrin were purchased from Sigma-Aldrich
(St. Louis, MO). Mannan is a ligand antagonist of human
mannose receptors. For purpose of easy labeling, the product
numbers of each oligosaccharide from Sigma are also included.
The background information of each product is listed in
Sigma-Aldrich catalog.
Mermaid is a DC-SIGN-likemolecule expressed by themarine
nematode Laxus oneistus. The carbohydrate recognition domain
of Mermaid shares both structural and functional similarity
with that of DC-SIGN as described (56). A recombinant form
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of Mermaid (His-Mermaid) was expressed and purified as
described (56).
Sequencing of Six O-Antigen Synthesis
Genes
wbyL, fcl, gmd, wzy, wbyI, and ddhB of 39 Y. pseudotuberculosis
strains and 8 Y. pestis strains were sequenced. First, these genes
were copied by Polymerase Chain Reaction using high-fidelity
DNA polymerase (PCR SuperMix, Transgene Biotech, Beijing).
And then the products were sent to perform bidirectional
Sanger sequencing. Primers for these O-antigen synthesis genes;
wbyL Forward 5′- GTCGGCATTGCTCATTCTATTG- 3′, wbyL
Reverse 5′- TCACTGGTTAATCGAACATCCC- 3′, fcl Forward
5′- TGCTGAAATGGTCGCTAGTG-3′, fcl Reverse 5′- AGA
GTCGCCATATCCAAATAGC-3′, gmd Forward 5′- AGGTGAT
GCCGCTATATTAGTG-3′, gmd Reverse 5′- GAGGTCAAGTT
CAGTACGATCC-3′, wzy-1 Forward 5′- TCGACTACCTT
CTCATTCTTGG-3′, wzy-1 Reverse 5′- TCACGACGAAGAG
CCTTTATAG-3′, wzy-2 Forward 5′- GGCCTCTTGTACCA
AACTTC-3′, wzy-2 Reverse 5′- TCCGAGAAATAGACAGTTA
CCC-3′, wbyI Forward 5′- TGTGTCAAGTTAGTCGGATATG-
3′, wbyI Reverse 5′- CTTGCGAAGACCATTTCATTAG-3′,
ddhB Forward 5′- GGCAGGGCACCTTGGAAG-3′, and ddhB
Reverse 5′- CCAGCTCAGCAATCTGTTGAC-3′. Sequencing
data was analyzed by BioNumerics Software Version 7 and
heatmap was made by R software.
Isolation of Mouse Peritoneal
Macrophages
The peritoneal macrophages were selected as our primary
cells. After the 6- to 8-week-old female mice were euthanized,
intact abdomen was exposed, cleaned with 70% ethanol and
opened. Five milliliter of RPMI was injected into intraperitoneal
cavity. Mouse abdomen was gently massaged for 3min and
then the lavage fluid was collected. The suspension containing
the macrophages was seeded in flasks and placed in a CO2
incubator for 2 h. The cell layers were washed 3 times to remove
non-adherent cells. Macrophages were then removed from the
plastic surface by incubating with citrate saline and re-seeded
for interaction assays or stained with antibodies to check the
expression level of receptors.
Adherence and Phagocytosis Assays
The assays for adherence and phagocytosis have been described
previously (81, 82). Briefly, host cells (CHO, HeLa, and
macrophages) were plated in 24 or 96-well plates. Cells were
suspended in RPMI with 2% FCS at a concentration of 4 ×
105/ml. One half ml each of these cell suspensions was added to
24-well plates and after addition of 50 µl of bacterial suspensions
at a concentration of 1 × 107 colony forming units (CFU)/ml,
the cells were allowed to incubate for 2.5 h (2 h for alveolar
macrophages) at 37◦C in the presence of 5% CO2. The cell
monolayers were then washed 3 times with PBS. The number
of associated bacteria (adherent and internalized) per cell was
quantified by washing the cells 3 times with RPMI containing
2% FCS and plating the culture after the cells were lysed by 0.5%
saponin (Calbiochem Corp., San Diego, CA).
To determine the internalization of bacteria, gentamicin,
which kills extracellular bacteria but cannot penetrate host cells,
was added into each well to a final concentration of 100µg/ml,
and the cultures were incubated for 60min. Cells were washed
twice to remove the antibiotics. Then, the cells were suspended in
PBS containing 0.5% saponin, diluted and plated on LB and GC
as well as Y. pestis plates. The level of internalization of bacteria in
these host cells was calculated by determining the CFU recovered
from lysed cells.
For the inhibition assay, reagents were added 20min prior
to the addition of bacteria at the following concentrations:
anti-SIGNR1 antibody, 5µg/ml; mannan, 500µg/ml; DC-SIGN-
like protein (Mermaid), 10µg/ml and anti-CD66, 5µg/ml.
The concentrations used were based on our preliminary
data, and were selected based on the fact that at these
concentrations, there was no influence on the survival of
bacteria and HeLa cells, or the interaction between pEXI and
HeLa-CEACAM3 (22–24, 82, 83).
Determination of Phagocytosis by Flow
Cytometry
The following method was used to supplement the survival-
based phagocytosis assay described previously (23). Briefly,
bacteria were suspended in RPMI medium containing 5- and
6-carboxyfluorescein diacetate, succinimidyl ester (CFDA-SE;
Molecular Probes, Eugene. OR) for 40min and washed twice
with RPMI to remove the excess dye. Labeled bacteria were
added to macrophage cultures for 2 h. Cell cultures were
washed twice to remove unbound bacteria. Macrophages plus
associated bacteria were fixed with 2% paraformaldehyde.
Before flow cytometry, a 1:10 dilution of Trypan blue (0.4%,
Sigma, St. Louis, MO) was added to the fixed cell cultures
and the mixture was incubated at ambient temperature for
10min (23) to quench the fluorescence from extracellular
labeled bacteria. Trypan blue blocks fluorescence but cannot
penetrate host cells, therefore, fluorescence from internalized
bacteria will not be influenced by addition of Trypan blue.
The rate of bacterial internalization was determined by
comparing the intensity fluorescence-positive macrophages
with various bacteria. The higher of the fluorescence-
intensity shows, the more of bacteria are phagocytosed
by macrophages.
In vivo Phagocytosis Assays
One milliliter of bacterial suspensions (OD = 0.1) were
injected into 6- to 8-week-old female mouse intraperitoneal
cavity. Mouse abdomen was gently massaged for 1min.
After 1.5 h, mice were euthanized and another 4ml of
RPMI with 2% FCS were immediately injected into each
mouse peritoneal cavity and the abdomen was gently
massaged for another 1min. The intraperitoneal fluids or
exudates were collected, and the numbers of cells were
counted for each collection of intraperitoneal lavage. 1 ×
106 was seeded onto each well of 24-well plates, containing
RPMI with 2% FCS and gentamycin at concentration of
100µg/ml, and were then incubated for 1.5 h to allow the
macrophages adhere to plates and kill the extracellular
bacteria. Each well was washed three times with RPMI
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with 2% FCS to remove non-adhered cells and lysed
with saponin, followed the same procedures as in vitro
phagocytosis assays.
Animal Challenging for Dissemination and
Infection
Six- to eight-week-old female C57BL/6J and SIGNR1 KO mice
were used in the following experiments. The dissemination rate
was defined as the transport of Y. pestis to LN, spleen, and liver.
The infectivity was defined as the mortality after inoculations
of pathogens.
The protocol follows a similar assay we previously developed
(26, 27). Y. pestis were cultured at 26◦C to avoid the expression
of OPM capsule and then suspended in PBS at a concentration
of OD600 = 1.5 in PBS. Hundred microliters of the Yersinia
suspension was injected in hind paws of mice. It should be noted
30min before inoculation, mice were injected with ampicillin
at a final concentration of 50µg/g of mouse body weight
to maintain the plasmid-based expression of O-antigen. (1)
For CFU determination, the mice were euthanized and the
inguinal lymph nodes were isolated 24 h post-injection. The
isolated inguinal lymph nodes were then homogenized and
lysed with 0.5% Triton X-100 to release the bacteria prior to
plating onto agar plates containing ampicillin. The total isolated
CFU of inguinal lymph nodes per mouse were defined as the
dissemination rate. (2) For bioluminescence imaging, C57BL/6J
mice were inoculated with Y. pestis 1418 and Y. pestis 1418-
O+ transformed with the plasmid pXEN-18 which expresses the
lux genes. The bioluminescence signal was detected by Night
OWL II LB983 imaging system (Berthold Technologies, Bad
Wildbad, Germany).
Statistical Analyses
All statistical analyses were completed using Prism software,
Version 6 (Graph Pad, San Diego, CA, USA). Statistical
significance was assessed using Student’s unpaired t-test. Survival
assay was analyzed by log-rank test.
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